Q1 Earnings Forecast for Enovix Issued By Northland Capmk

Enovix Co. (NASDAQ:ENVX) – Equities researchers at Northland Capmk issued their Q1 2026 earnings per share estimates for Enovix in a research report issued on Thursday, February 20th. Northland Capmk analyst G. Richard anticipates that the company will earn ($0.27) per share for the quarter. The consensus estimate for Enovix’s current full-year earnings is ($1.01) per share. Northland Capmk also issued estimates for Enovix’s Q2 2026 earnings at ($0.27) EPS, Q3 2026 earnings at ($0.27) EPS and Q4 2026 earnings at ($0.27) EPS.

Enovix (NASDAQ:ENVX) last posted its quarterly earnings data on Wednesday, February 19th. The company reported ($0.17) earnings per share for the quarter, topping the consensus estimate of ($0.18) by $0.01. The firm had revenue of $9.72 million during the quarter, compared to analysts’ expectations of $8.77 million. Enovix had a negative net margin of 963.17% and a negative return on equity of 96.99%.

Several other equities analysts have also recently weighed in on ENVX. Janney Montgomery Scott cut Enovix from a “buy” rating to a “neutral” rating and set a $10.00 price objective on the stock. in a report on Thursday, October 31st. Benchmark reaffirmed a “buy” rating and issued a $25.00 target price on shares of Enovix in a research report on Wednesday, October 30th. Craig Hallum dropped their price target on shares of Enovix from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $30.00 price objective on shares of Enovix in a research note on Thursday. Two analysts have rated the stock with a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $20.30.

Enovix Trading Down 6.6 %

NASDAQ:ENVX opened at $10.72 on Monday. The company has a current ratio of 3.77, a quick ratio of 3.61 and a debt-to-equity ratio of 0.99. Enovix has a 1-year low of $5.70 and a 1-year high of $18.68. The firm has a market capitalization of $1.91 billion, a price-to-earnings ratio of -7.39 and a beta of 1.87. The business’s 50-day moving average price is $11.15 and its two-hundred day moving average price is $10.29.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the company. Fifth Third Bancorp raised its holdings in shares of Enovix by 66.7% in the fourth quarter. Fifth Third Bancorp now owns 2,500 shares of the company’s stock worth $27,000 after buying an additional 1,000 shares during the last quarter. Hodges Capital Management Inc. lifted its position in Enovix by 1.8% during the 4th quarter. Hodges Capital Management Inc. now owns 57,500 shares of the company’s stock worth $625,000 after acquiring an additional 1,000 shares during the period. Wealthcare Advisory Partners LLC grew its stake in Enovix by 6.2% during the 4th quarter. Wealthcare Advisory Partners LLC now owns 20,952 shares of the company’s stock valued at $228,000 after purchasing an additional 1,214 shares during the last quarter. Victory Capital Management Inc. raised its stake in shares of Enovix by 6.8% in the fourth quarter. Victory Capital Management Inc. now owns 19,695 shares of the company’s stock worth $214,000 after purchasing an additional 1,257 shares during the last quarter. Finally, Rockefeller Capital Management L.P. boosted its position in Enovix by 6.7% in the third quarter. Rockefeller Capital Management L.P. now owns 21,656 shares of the company’s stock valued at $202,000 after buying an additional 1,367 shares during the last quarter. Institutional investors own 50.92% of the company’s stock.

Insiders Place Their Bets

In other news, Director Betsy S. Atkins sold 75,000 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $9.73, for a total value of $729,750.00. Following the sale, the director now owns 99,497 shares of the company’s stock, valued at approximately $968,105.81. This represents a 42.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 15.70% of the company’s stock.

About Enovix

Enovix Corporation designs, develops, and manufactures lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.